Academician
MERVE ZENGİN
Doktor Öğretim Üyesi
Hacettepe Üniversitesi Eczacılık Fakültesi Eczacılık Meslek Bilimleri Bölümü
Research topics OpenAlex
- Cholinesterase and Neurodegenerative Diseases4
- Computational Drug Discovery Methods4
- Synthesis and biological activity3
- Synthesis and Biological Evaluation2
- Enzyme function and inhibition1
- Synthesis and Catalytic Reactions1
- Phenothiazines and Benzothiazines Synthesis and Activities1
- Synthesis and Characterization of Pyrroles1
- Alzheimer's disease research and treatments1
- Receptor Mechanisms and Signaling1
- Chemical synthesis and alkaloids1
- Click Chemistry and Applications1
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Farmasotik Kimya
Citation impact
OpenAlex YÖKSİS articles matched in OpenAlex: 9
h-index
5
Percentile in Türkiye: 61
#1,267 of 2,367 at their university by h-index
- i10-index
- 2
- Total citations
- 85 Top 39% in Türkiye
- Per article
- 9.4
- FWCI
- 1.22 1.00 = world average
- World top 1%
- 0
- World top 10%
- 1
Most cited articles
- Design and synthesis of new 2-oxoquinoxalinyl-1,2,4-triazoles as antitumor VEGFR-2 inhibitors
- Insights into the chemistry and therapeutic potential of acrylonitrile derivatives
- Antifungal Azole Derivatives Featuring Naphthalene Prove Potent and Competitive Cholinesterase Inhibitors with Potential CNS Penetration According to the in Vitro and in Silico Studies
How is this computed?
h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included.
Field ranking
YÖKSİS ?-
Main field Sağlık Bilimleri Temel AlanıPoints rank #22,838/ 39,749 top 57.5% At university #852/ 1,078Score 8.05 journal 7.8 · OA add 0.25
- Article rank25,910/39,749
- Scopus rank21,975/39,749
- WoS rank21,662/39,749
- YÖKSİS9
- Scopus9
- WoS9
-
Side field Farmasotik KimyaPoints rank #114/ 206 top 55.3% At university #11/ 14Score 8.05 journal 7.8 · OA add 0.25
- Article rank121/206
- Scopus rank112/206
- WoS rank108/206
- YÖKSİS9
- Scopus9
- WoS9
Collaboration network
From the author lists of YÖKSİS publication records. Duplicate records of a work count once; institutions are co-authors’ current YÖKSİS affiliations.
- Co-authors
- 17
- With an akaturk profile
- 10
- Turkish institutions
- 3
- Co-authored works
- %100
Academic co-authors 10
- OYA ÜNSAL TAN Profesör · Hacettepe Üniversitesi same university 6
- SUAT SARI Doçent · Hacettepe Üniversitesi same university 3
- SUNA SABUNCUOĞLU Profesör · Hacettepe Üniversitesi same university 3
- BURAK BARUT Doçent · Karadeniz Teknik Üniversitesi 2
- DİDEM AKKAYA Araştırma Görevlisi · Karadeniz Teknik Üniversitesi 2
- ZEKİYE TUBA TÜYLÜ KÜÇÜKKILINÇ Profesör · Hacettepe Üniversitesi same university 2
- BEYZA AYAZGÖK Araştırma Görevlisi · Hacettepe Üniversitesi same university 1
- MEHMET ABDULLAH ALAGÖZ Doçent · İnönü Üniversitesi 1
- SELMA SARAÇ TARHAN Profesör · Başkent Üniversitesi 1
- ZEYNEP ÖZDEMİR Doçent · İnönü Üniversitesi 1
National collaboration 3 institutions
Within own university9 joint works · Hacettepe Üniversitesi
- Karadeniz Teknik Üniversitesi 2 works · 2 academics
- Başkent Üniversitesi 1 works · 1 academics
- İnönü Üniversitesi 1 works · 2 academics
Other co-authors (incl. international) 7
AYLA BALKAN 3ARZU KARAKURT 2Reem Arafa 2Agata SiwekMonika MarcinkowskaSEDA ÖNDERSibel Yurtoğlu
Authors without an akaturk profile (international researchers, retired or former academics, students, clinicians) are grouped by name spelling; short forms such as “Gulluce M.” join the single full name they match.
Indexes and citation percentiles
?Top 1%0
Top 10%1
Avg · n 9
%66.5
Other counts
Scopus (SJR)
- YÖKSİS rows 9
WoS (JCR)
- YÖKSİS rows 9
Articles
Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.
Journals with publications
6 journals
Narrow down
Article list
- 2026 Targeting VEGFR-2 with piperazine bridged indolin-2-one derivatives YÖKSİS SJR Q1 JCR Q1 OpenAlex 85.2%
- 2024 Design and Discovery of New Dual Carbonic Anhydrase IX and VEGFR‐2 Inhibitors Based on the Benzenesulfonamide‐Bearing 4‐Thiazolidinones/2,4‐Thiazolidinediones Scaffold YÖKSİS SJR Q2 JCR Q1 OpenAlex 69.7%
- 2024 Azoles display promising anticonvulsant effects through possible PPAR-α activation YÖKSİS SJR Q2 JCR Q4 OpenAlex 62.5%
- 2024 Antitüberküler Bileşiklerde Piperazin Yapısı YÖKSİS SJR Q2 JCR Q1 OpenAlex 7.5%
- 2023 Azole derivatives inhibit wildtype butyrylcholinesterase and its common mutants YÖKSİS SJR Q2 JCR Q2 OpenAlex 69.1%
- 2022 Antifungal Azole Derivatives Featuring Naphthalene Prove Potent and Competitive Cholinesterase Inhibitors with Potential CNS Penetration According to the in Vitro and in Silico Studies YÖKSİS SJR Q2 JCR Q3 OpenAlex 73.2%
- 2022 Insights into the chemistry and therapeutic potential of acrylonitrile derivatives YÖKSİS SJR Q2 JCR Q1 OpenAlex 74.5%
- 2022 Design and synthesis of new 2-oxoquinoxalinyl-1,2,4-triazoles as antitumor VEGFR-2 inhibitors YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 95.2%
- 2019 Design and Synthesis of 2-Substitutedphenyl Benzo[D]Thiazole Derivatives and Their β-Amyloid Aggregation and Cholinesterase Inhibitory Activities YÖKSİS SJR Q4 JCR Q4 OpenAlex 61.7%